Novo Nordisk A/S (NVO)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 112.12 |
| Open | 112.68 |
| Bid | 107.14 x 1200 |
| Ask | 118.75 x 800 |
| Day's range | 112.08 - 113.77 |
| 52-week range | 82.82 - 122.16 |
| Volume | |
| Avg. volume | 1,476,990 |
| Market cap | 255.777B |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | 37.21 |
| EPS (TTM) | 3.03 |
| Earnings date | N/A |
| Forward dividend & yield | 1.57 (1.49%) |
| Ex-dividend date | 25 Mar 2022 |
| 1y target est | 129.66 |
- Zacks
Here's Why Investors Should Retain CVS Health (CVS) For Now
Investors are optimistic about CVS Health's (CVS) robust revenue growth across its operating segments.
- Zacks
Novartis (NVS) Gets Positive CHMP Opinion for Scemblix in CML
The CHMP recommends approval of Novartis' (NVS) Scemblix for treating adult patients with chronic myeloid leukemia. EU also approves label expansion of Cosentyx.
- Zacks
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
The CHMP recommends approval of AbbVie's (ABBV) Rinvoq for treating adults with active non-radiographic axial spondyloarthritis.
© 2022 Yahoo. All rights reserved.
